CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+13.37%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.86B
AUM Growth
+$2.86B
(-4.3%)
Cap. Flow
-$350M
Cap. Flow
% of AUM
-12.24%
Top 10 Holdings %
Top 10 Hldgs %
65.05%
Holding
50
New
6
Increased
11
Reduced
10
Closed
10
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$81.3M |
| 2 |
Tenet Healthcare
THC
|
$48.8M |
| 3 |
GSK
GSK
|
$43.9M |
| 4 |
Qiagen
QGEN
|
$37.4M |
| 5 |
Align Technology
ALGN
|
$36.9M |
Top Sells
| 1 |
Viatris
VTRS
|
$111M |
| 2 |
Charles River Laboratories
CRL
|
$98.4M |
| 3 |
Universal Health Services
UHS
|
$77.5M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$67.8M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$63.9M |
Sector Composition
| 1 | Healthcare | 98.44% |
| 2 | Consumer Discretionary | 0.56% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $339M | 11.63% | 7,000,000 -500,000 | -7% | -$24.2M |
|
|
2
Universal Health Services
UHS
$11.6B
| $240M | 8.21% | 1,700,000 -550,000 | -24% | -$77.5M |
|
|
3
Viatris
VTRS
$12.3B
| $223M | 7.63% | 20,000,000 -10,000,000 | -33% | -$111M |
|
|
4
Tenet Healthcare
THC
$16.3B
| $195M | 6.69% | 4,000,000 +1,000,000 | +33% | +$48.8M |
|
|
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
| $187M | 6.41% | 5,000,000 +2,175,000 | +77% | +$81.3M |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $162M | 5.56% | 1,250,000 -250,000 | -17% | -$32.4M |
|
7
Zimmer Biomet
ZBH
$21B
| $159M | 5.47% | 1,250,000 -150,000 | -11% | -$19.1M |
|
|
8
GSK
GSK
$79.9B
| $132M | 4.52% | 3,750,000 +1,250,000 | +50% | +$43.9M |
|
9
Select Medical
SEM
$1.61B
| $119M | 4.09% | 4,800,000 | – | – |
|
10
PTC Therapeutics
PTCT
$3.92B
| $105M | 3.6% | 2,750,000 +300,000 | +12% | +$11.5M |
|
11
Myriad Genetics
MYGN
$593M
| $102M | 3.48% | 7,000,000 +2,000,000 | +40% | +$29M |
|
12
Perrigo
PRGO
$3.27B
| $85.2M | 2.92% | 2,500,000 | – | – |
|
|
13
Align Technology
ALGN
$10.3B
| $79.1M | 2.71% | 375,000 +175,000 | +88% | +$36.9M |
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| $72.7M | 2.49% | 1,925,000 | – | – |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $64.3M | 2.2% | 500,000 +250,000 | +100% | +$32.1M |
|
16
Teva Pharmaceuticals
TEVA
$21.1B
| $63.8M | 2.19% | 7,000,000 -500,000 | -7% | -$4.56M |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $63.4M | 2.18% | 1,400,000 -600,000 | -30% | -$27.2M |
|
18
Dentsply Sirona
XRAY
$2.85B
| $56.2M | 1.93% | 1,765,000 +350,000 | +25% | +$11.1M |
|
19
Brookdale Senior Living
BKD
$1.83B
| $49.1M | 1.69% | 18,000,000 +2,000,000 | +13% | +$5.46M |
|
20
Quanterix
QTRX
$211M
| $47.4M | 1.63% | 3,425,000 +425,000 | +14% | +$5.89M |
|
|
21
Qiagen
QGEN
$10.1B
| $37.4M | 1.28% | +750,000 | New | +$37.4M |
|
22
Replimune Group
REPL
$422M
| $27.2M | 0.93% | +1,000,000 | New | +$27.2M |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $26.7M | 0.92% | +700,000 | New | +$26.7M |
|
24
Collegium Pharmaceutical
COLL
$1.22B
| $24.4M | 0.84% | 1,050,000 | – | – |
|
25
ZimVie
ZIMV
$532M
| $24.3M | 0.83% | 2,600,000 | – | – |
|